StockDuty ← Dashboard Sep 04, 2026 03:47 PM ET
SignalFDA/Bio

ABBV's Etentamig Meets Goals in Phase III Multiple Myeloma Study

Phase III success for etentamig signals pivotal regulatory and commercial upside for ABBV.

What changed
Why it matters
Phase III success for etentamig signals pivotal regulatory and commercial upside for ABBV.
Sources
eodhd
Related signals
PHASE 1 OF INDIA - US TRADE PACT HINGES ON SECTION 301 PROBE , OFFICIAL SAYS →PITNEY BOWES OUTLINES PHASE 2 STRATEGIC REVIEW WHILE PUSHING NEAREST DEBT MATURITY TO MARCH 2029 - SEEKINGALPHA →UNICYCIVE PLUMMETS FOLLOWING SECOND CRL FOR OLC FOR HYPERPHOSPHATEMIA - SEEKINGALPHA →